HMS Networks AB
HMS Networks AB (publ) has on February 4, 2021 purchased 50,000 shares (ISIN SE0009997018) for a price of SEK 308.65 per share. HMS Networks’ holdings of own shares amounts to 204,916 after the repurchase. The total number of outstanding shares in the company is 46,818,868. The repurchase has been made on Nasdaq Stockholm.
For more information, please contact:
Staffan Dahlström, CEO HMS, +46 (0)35 17 29 01
Joakim Nideborn, CFO HMS, +46 (0)35 710 6983
HMS Networks AB (publ) is a market-leading provider of solutions in industrial information and communication technology (Industrial ICT). HMS develops and manufactures products under the Anybus®, Ixxat®, Ewon® and Intesis® brands. Development takes place at the headquarter in Halmstad and also in Ravensburg, Nivelles, Igualada, Wetzlar Buchen and Delft. Local sales and support are handled by branch offices in Germany, USA, Japan, China, Singapore, Italy, France, Spain, the Netherlands, India, UK, Sweden, South Korea and UAE, as well as through a worldwide network of distributors and partners. HMS employs over 700 people and reported sales of SEK 1,467 million in 2020. HMS is listed on the NASDAQ OMX in Stockholm, category Mid Cap, Information Technology.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
798 Art District26.4.2025 14:44:55 CEST | Press release
798 Art District and Beijing International Film Festival Jointly Launch “Art Lights the Screen” – A Cultural Feast of Film and Art
Atlantic Petroleum P/F26.4.2025 14:32:40 CEST | Press release
Summons for the Annual General Meeting of P/F Atlantic Petroleum
Financière de Tubize SA26.4.2025 08:00:00 CEST | Press release
Financière de Tubize - Dividend approval
MoonLake Immunotherapeutics AG25.4.2025 22:05:00 CEST | Press release
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
T-knife Therapeutics25.4.2025 19:00:00 CEST | Press release
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom